[{"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-001", "question": "A 39-year-old man presents with recurrent pancreatitis and is found to have a 2.5-cm enhancing mass in the pancreatic head that encases the intrapancreatic common bile duct, with upstream dilatation but no vascular involvement. EUS-FNA is nondiagnostic twice. CA 19-9 is normal. IgG4 level is mildly elevated at 180 mg/dL (ULN 135). CT shows a capsule-like rim around the lesion and diffuse, sausage-shaped enlargement of the gland. Which management approach is most appropriate?", "options": ["Trial of high-dose corticosteroids with close radiologic follow-up before considering surgery", "Pancreaticoduodenectomy because focal autoimmune pancreatitis cannot be reliably distinguished from adenocarcinoma", "Repeat EUS-FNA with core needle and flow cytometry to exclude lymphoma", "Observation alone with serial imaging in 6 months given low CA 19-9 and mild symptoms", "ERCP with biliary brushing cytology and stent placement, with surgery only if cytology is positive"], "answer": "A", "answer_index": 0, "explanation": "Imaging findings (capsule-like rim, sausage-shaped gland) and elevated IgG4 strongly suggest type 1 autoimmune pancreatitis; a steroid trial with close monitoring is accepted to avoid unnecessary Whipple when malignancy is not strongly supported. Immediate pancreaticoduodenectomy (B) is premature. Repeat biopsy (C) is less helpful given characteristic features. Observation alone (D) ignores ongoing pancreatitis and biliary obstruction. ERCP cytology (E) has low sensitivity and does not treat underlying inflammatory disease.", "generator_model": "gpt-5.1-2025-11-13", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed130-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed130.jsonl", "pred": "A", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- 39-year-old with recurrent pancreatitis\n- 2.5-cm enhancing mass in pancreatic head\n- Encases intrapancreatic CBD with upstream dilatation\n- No vascular involvement\n- EUS-FNA nondiagnostic twice\n- Normal CA 19-9\n- Mildly elevated IgG4 (180 mg/dL)\n- Capsule-like rim around lesion\n- Diffuse, sausage-shaped enlargement of gland\n\nDiagnosis Considerations:\n\nThe clinical presentation is highly suggestive of Type 1 Autoimmune Pancreatitis (AIP):\n- Recurrent pancreatitis\n- Focal mass in pancreatic head\n- Elevated IgG4 (though mildly)\n- Capsule-like rim (characteristic finding)\n- Diffuse sausage-shaped gland enlargement (characteristic)\n- Normal CA 19-9 (argues against malignancy)\n- Nondiagnostic EUS-FNA (doesn't help distinguish, but doesn't exclude AIP)\n\nDifferential Diagnosis:\n- Pancreatic adenocarcinoma (less likely given: normal CA 19-9, capsule-like rim, sausage-shaped gland, elevated IgG4, recurrent pancreatitis history)\n- Lymphoma (less likely given imaging features)\n\nManagement Approach:\n\nThe International Consensus Diagnostic Criteria (ICDC) for AIP support a trial of corticosteroids as a diagnostic and therapeutic approach. A dramatic response to steroids would confirm AIP diagnosis and avoid unnecessary surgery.\n\nWhy each option:\n- A. Trial of corticosteroids: This is the standard approach for suspected AIP. Dramatic response confirms diagnosis and avoids surgery. This is appropriate given the clinical picture.\n- B. Immediate surgery: Too aggressive given strong clinical features of AIP and normal CA 19-9\n- C. Repeat EUS-FNA with flow cytometry: Unlikely to be helpful; already done twice\n- D. Observation alone: Inappropriate given symptomatic pancreatitis and biliary obstruction\n- E. ERCP with brushing: May be considered but doesn't address the underlying diagnosis; steroid trial is more appropriate first\n\nThe answer is A"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-002", "question": "A 72-year-old man with long-standing COPD (FEV1 35% predicted), chronic hypercapnia, and recent admission for an acute exacerbation requiring noninvasive ventilation is evaluated 3 weeks after discharge. He continues to have daytime somnolence and morning headaches despite resolution of wheeze and normalization of oxygenation on 2 L/min nasal cannula. ABG on his usual oxygen shows pH 7.37, PaCO2 58 mm Hg, PaO2 70 mm Hg, HCO3- 33 mEq/L. Overnight oximetry reveals sustained hypoventilation with episodic desaturations but no significant obstructive apneas. He is adherent to inhaled therapy and pulmonary rehab. What is the most appropriate next step in chronic management to improve mortality?", "options": ["Increase long-term oxygen therapy to maintain PaO2 >80 mm Hg", "Start nocturnal noninvasive ventilation with targeted normalization of PaCO2", "Add chronic low-dose oral prednisone", "Begin acetazolamide at night to stimulate ventilation", "Switch to high-flow nasal cannula at home during sleep"], "answer": "B", "answer_index": 1, "explanation": "In stable COPD with chronic hypercapnic respiratory failure, particularly after a hypercapnic exacerbation, nocturnal noninvasive ventilation targeting PaCO2 reduction reduces mortality and hospitalizations. Increasing oxygen can worsen hypercapnia; chronic steroids confer harm; acetazolamide has limited long-term data; home high-flow therapy improves comfort but lacks robust mortality benefit compared with NIV in this phenotype.", "generator_model": "gpt-5.1-2025-11-13", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed123", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed123-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed123.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- 72-year-old with severe COPD (FEV1 35%)\n- Chronic hypercapnia (baseline elevated CO2)\n- Recent exacerbation requiring NIV\n- Persistent daytime somnolence and morning headaches (signs of CO2 retention)\n- Current ABG: pH 7.37, PaCO2 58, PaO2 70, HCO3- 33 (chronic respiratory acidosis with metabolic compensation)\n- Overnight oximetry shows hypoventilation with desaturations, NO obstructive apneas\n- Already on appropriate inhaled therapy and pulmonary rehab\n\nClinical Interpretation:\nThe patient has:\n1. Hypercapnic respiratory failure (PaCO2 58)\n2. Daytime somnolence + morning headaches = classic signs of nocturnal hypoventilation\n3. Nocturnal desaturations without obstructive apneas = hypoventilation pattern\n4. This is \"overlap syndrome\" - COPD with concurrent hypoventilation\n\nAnalysis of Options:\n\nA. Increase O2 to PaO2 >80: This could worsen CO2 retention by removing hypoxic drive to breathe in a CO2-retainer. Not appropriate.\n\nB. Nocturnal NIV with targeted normalization of PaCO2: This directly addresses the hypoventilation problem. NIV improves ventilation, reduces CO2, and improves oxygenation simultaneously. Multiple studies show NIV improves survival in COPD patients with chronic hypercapnia, especially those with nocturnal hypoventilation.\n\nC. Chronic prednisone: No indication; already treated for exacerbation. Increases infection risk.\n\nD. Acetazolamide: Weak evidence; not first-line for this presentation.\n\nE. High-flow nasal cannula at home: This is for acute settings, not chronic home management, and doesn't address the ventilation problem.\n\nWhy B is Best:\n- The patient has documented nocturnal hypoventilation causing symptoms\n- NIV is evidence-based for COPD with chronic hypercapnia\n- It improves both oxygenation AND ventilation (removes CO2)\n- Improves mortality in appropriate candidates\n- Addresses the root cause of daytime somnolence and morning headaches\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-003", "question": "A 55-year-old man from a region endemic for Lyme disease presents with 1 week of rapidly progressive bilateral leg weakness and numbness ascending from the feet, severe radicular pain, and new urinary retention. He was treated with oral doxycycline 3 weeks ago for erythema migrans following a hiking trip. Exam: symmetric lower extremity weakness 3/5 proximally and distally, hyperreflexia with bilateral Babinski signs, decreased pinprick below T10, preserved vibration sense in toes, and saddle hypesthesia. Cranial nerves are normal. MRI spine with contrast: multifocal enhancing lesions in the thoracic cord with associated leptomeningeal enhancement; no compressive lesion. CSF: WBC 220/µL (80% lymphocytes), protein 120 mg/dL, glucose 45 mg/dL (serum 90), oligoclonal bands present; CSF Lyme antibody index is elevated. HIV, syphilis, and TB tests are negative. What is the most appropriate treatment?", "options": ["High-dose IV methylprednisolone alone for presumed idiopathic transverse myelitis", "IV ceftriaxone 2 g daily for 4 weeks without steroids", "IV ceftriaxone 2 g daily plus high-dose IV methylprednisolone", "Oral doxycycline 100 mg BID for 28 days plus high-dose oral prednisone taper", "Plasma exchange for 5-7 sessions followed by IV ceftriaxone"], "answer": "B", "answer_index": 1, "explanation": "This is Lyme neuroborreliosis with meningomyelitis confirmed by elevated CSF Lyme antibody index and appropriate clinical picture; standard treatment is prolonged IV ceftriaxone without routine adjunctive steroids. Steroids alone (A) are inappropriate and may worsen infection. Adding high-dose steroids to antibiotics (C) has no proven benefit and may be harmful. Oral doxycycline (D) is inadequate for CNS parenchymal involvement. Plasma exchange (E) is used in severe autoimmune demyelination (e.g., NMO, ADEM) and is not indicated here once Lyme is confirmed.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed124.jsonl", "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n- Lyme disease endemic region, recent erythema migrans treated with doxycycline 3 weeks ago\n- Rapidly progressive bilateral leg weakness and numbness (ascending)\n- Severe radicular pain\n- Urinary retention\n- Hyperreflexia with Babinski signs (upper motor neuron signs)\n- Saddle hypesthesia and sensory level at T10\n- MRI: multifocal enhancing thoracic cord lesions with leptomeningeal enhancement\n\nCSF Findings:\n- Lymphocytic pleocytosis (220/µL, 80% lymphocytes)\n- Elevated protein (120 mg/dL)\n- Low glucose (45 mg/dL with serum 90) - hypoglycorrhachia\n- Oligoclonal bands present\n- Elevated CSF Lyme antibody index - diagnostic for neuroborreliosis\n\nDiagnosis:\nThis is Lyme neuroborreliosis with myelitis (Lyme meningomyelitis). The elevated CSF Lyme antibody index is the key diagnostic finding. The patient was inadequately treated with oral doxycycline for what appears to be disseminated Lyme disease.\n\nTreatment Considerations:\n\nThe CNS manifestations of Lyme disease (neuroborreliosis with myelitis) require:\n1. IV antibiotics - Oral doxycycline is insufficient for CNS penetration in neuroborreliosis. IV ceftriaxone is the standard of care (2g IV q12h for 14-28 days)\n2. Steroids - While controversial, high-dose IV methylprednisolone is often used in acute myelitis to reduce inflammation and prevent further neurological deterioration, especially given the rapidly progressive nature and significant cord involvement\n\nEvaluating Options:\n- A: Steroids alone without antibiotics is inappropriate for confirmed Lyme neuroborreliosis\n- B: IV ceftriaxone alone is reasonable but omits steroids for acute myelitis\n- C: IV ceftriaxone PLUS high-dose IV methylprednisolone addresses both the infection and acute inflammatory myelitis\n- D: Oral doxycycline is inadequate for CNS Lyme disease\n- E: Plasma exchange is not standard for Lyme neuroborreliosis\n\nThe answer is C"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-004", "question": "A 4-year-old girl with newly diagnosed steroid-sensitive nephrotic syndrome starts high-dose prednisone 2 mg/kg/day. Baseline blood pressure and renal function were normal. After 3 weeks she achieves complete remission of proteinuria, but blood pressure is now consistently at the 98th percentile systolic and 99th percentile diastolic for age/height. Labs: normal electrolytes, creatinine 0.3 mg/dL, albumin 3.5 g/dL, and a normal echocardiogram. She has no headaches or visual changes. Which of the following is the most appropriate next step in management of her hypertension?", "options": ["Initiate an ACE inhibitor and maintain the current steroid dose until 6 weeks are completed", "Switch from daily to alternate-day prednisone dosing immediately and start a calcium channel blocker", "Begin a low-dose thiazide diuretic while continuing full-dose prednisone and sodium restriction", "Add tacrolimus and rapidly taper prednisone over 5 days while observing blood pressure", "Discontinue prednisone abruptly and monitor for adrenal insufficiency while starting an ARB"], "answer": "B", "answer_index": 1, "explanation": "In steroid-sensitive nephrotic syndrome with early remission and steroid-induced hypertension, the recommended approach is early transition to alternate-day prednisone while treating hypertension with an agent such as a calcium channel blocker; this reduces steroid toxicity without compromising remission. Abrupt discontinuation risks disease relapse and adrenal suppression, and ACEi/ARB are less favored for primary BP control with normal renal function and no persistent proteinuria.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "B", "model_outputs": "Let me work through this systematically.\n\nClinical Context:\n- 4-year-old with steroid-sensitive nephrotic syndrome (SSNS)\n- Achieved complete remission on high-dose prednisone (2 mg/kg/day) after 3 weeks\n- Developed hypertension (98th-99th percentile) - likely steroid-induced\n- No end-organ damage (normal echo, no headaches/visual changes)\n- Normal renal function and electrolytes\n\nKey Considerations:\n\n1. Cause of hypertension: This is steroid-induced hypertension in a child who has achieved remission\n\n2. Standard SSNS management: After achieving remission, the typical approach is to transition from daily to alternate-day dosing to reduce steroid side effects while maintaining efficacy\n\n3. Steroid-induced hypertension management: The best approach is to reduce steroid exposure rather than add antihypertensive agents if possible\n\n4. Evaluation of options:\n   - A: Maintains full-dose steroids for 6 weeks - prolongs steroid exposure unnecessarily\n   - B: Switches to alternate-day dosing (standard practice after remission) AND adds calcium channel blocker - this addresses both the steroid dose and the hypertension\n   - C: Adds diuretic while maintaining full-dose steroids - thiazides can worsen metabolic complications and doesn't reduce steroid exposure\n   - D: Tacrolimus addition with rapid taper is not standard for SSNS; rapid taper risks relapse\n   - E: Abrupt discontinuation risks adrenal insufficiency and relapse\n\nBest Answer:\nOption B is most appropriate because:\n- Switching to alternate-day dosing is the standard next step after achieving remission in SSNS\n- This reduces steroid side effects including hypertension\n- Adding a calcium channel blocker provides immediate blood pressure control while the steroid reduction takes effect\n- This is the most physiologic approach - reducing the cause while managing the symptom\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-005", "question": "A 28-year-old man is brought to the ED after a high-speed MVC with hypotension and abdominal distension. FAST is positive in Morrison's pouch and pelvis. He undergoes emergent laparotomy with splenectomy and packing of diffuse hepatic oozing. Postoperatively in the ICU, he remains hypotensive despite 6 units PRBC, 6 units FFP, and 1 apheresis platelet unit. Core temperature is 33.5°C, pH 7.09, ionized calcium 0.9 mmol/L, and INR 2.4. Oozing continues from surgical drains. Which of the following is the next best step in management of his ongoing bleeding?", "options": ["Administer recombinant factor VIIa to promote thrombin generation", "Provide additional FFP and platelets guided by clinical judgment", "Initiate aggressive rewarming, calcium replacement, and correction of acidosis before further factor therapy", "Begin a continuous IV heparin infusion to treat consumptive coagulopathy", "Administer desmopressin to improve platelet adhesion"], "answer": "C", "answer_index": 2, "explanation": "This patient has the lethal triad of hypothermia, acidosis, and coagulopathy in massive trauma; correcting temperature, acidosis, and ionized calcium is crucial for coagulation to work and should precede or accompany further factor replacement. Recombinant factor VIIa is less effective and risky in this physiologic state, and empiric heparin or DDAVP will not address the fundamental problem.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "target_topic", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "C", "model_outputs": "Let me analyze this case systematically.\n\nClinical Presentation:\n- Post-trauma, post-operative patient with ongoing bleeding\n- Hypotension despite massive transfusion (6 PRBC, 6 FFP, 1 platelet unit)\n- Core temperature: 33.5°C (hypothermia)\n- pH: 7.09 (severe acidosis)\n- Ionized calcium: 0.9 mmol/L (hypocalcemia)\n- INR: 2.4 (coagulopathy)\n- Continued oozing from drains\n\nKey Diagnosis: Trauma-Induced Coagulopathy (TIC) with the \"Lethal Triad\"\n\nThe patient exhibits the classic lethal triad:\n1. Hypothermia (33.5°C)\n2. Acidosis (pH 7.09)\n3. Coagulopathy (INR 2.4, ongoing bleeding)\n\nAnalysis of Options:\n\nA. Recombinant factor VIIa - While this can promote thrombin generation, it's not indicated as first-line in the setting of uncorrected hypothermia and acidosis, which are the PRIMARY drivers of coagulopathy here.\n\nB. Additional FFP and platelets - This is empiric transfusion without addressing the underlying reversible causes of coagulopathy.\n\nC. Aggressive rewarming, calcium replacement, and correction of acidosis - This addresses the ROOT CAUSES of the coagulopathy. Hypothermia and acidosis impair coagulation cascade function and platelet function. Hypocalcemia directly impairs coagulation. These must be corrected FIRST before expecting factor therapy to work.\n\nD. Heparin infusion - Contraindicated in active bleeding; this would worsen coagulopathy.\n\nE. Desmopressin - Not indicated; this patient needs correction of reversible physiologic derangements, not platelet adhesion improvement.\n\nRationale for C:\nThe lethal triad of hypothermia, acidosis, and coagulopathy is a well-recognized phenomenon in trauma. The coagulopathy in this case is primarily due to:\n- Hypothermia impairing enzymatic reactions\n- Acidosis reducing coagulation factor activity\n- Hypocalcemia directly affecting the coagulation cascade\n\nThese must be corrected BEFORE administering additional factors, as factor therapy will be ineffective in the setting of uncorrected hypothermia and acidosis.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-006", "question": "A 28-year-old G1P0 woman at 33 weeks' gestation presents to the ED with acute dyspnea, pleuritic chest pain, and near syncope. HR 132/min, BP 82/48 mm Hg, RR 30/min, SpO2 89% on 6 L nasal cannula. Bedside echo reveals a dilated RV with McConnell sign and septal flattening. CTA is unavailable; lower-extremity duplex is pending. She is consentable and has no contraindications to thrombolysis. Fetal heart tones are 150 bpm with moderate variability. Which management is most appropriate now?", "options": ["Systemic thrombolysis with weight-based alteplase bolus and infusion", "Urgent catheter-directed thrombolysis with reduced-dose alteplase", "Immediate transfer for surgical embolectomy with cardiopulmonary bypass", "Initiate high-dose unfractionated heparin and defer reperfusion until postpartum", "Administer tenecteplase as a single IV bolus followed by heparin"], "answer": "A", "answer_index": 0, "explanation": "She has high-risk (massive) pulmonary embolism with shock in late pregnancy; systemic thrombolysis is recommended when no absolute contraindications exist, as maternal survival takes priority and pregnancy is only a relative contraindication. Catheter-directed therapy or surgical embolectomy may be considered when thrombolysis is contraindicated or fails, not as first-line; deferring reperfusion is unsafe, and tenecteplase bolus lacks robust pregnancy-specific safety and dosing data compared with standard alteplase protocols.", "generator_model": "gpt-5.1-2025-11-13", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed125.jsonl", "pred": "B", "model_outputs": "Let me work through this systematically.\n\nClinical Presentation:\n- 28-year-old pregnant woman (33 weeks) with acute dyspnea, pleuritic chest pain, near syncope\n- Hemodynamically unstable: HR 132, BP 82/48, RR 30, SpO2 89%\n- Echo findings: dilated RV, McConnell sign, septal flattening (classic for acute RV strain)\n- Fetal status: reassuring (FHT 150 with moderate variability)\n- High suspicion for pulmonary embolism (PE)\n\nKey Clinical Features:\n- This is a massive/submassive PE (hemodynamic instability with RV dysfunction)\n- Patient is pregnant (33 weeks gestation)\n- Patient is hemodynamically unstable (hypotensive, tachycardic, hypoxic)\n- CTA unavailable but clinical picture is highly suggestive\n- Patient is consentable with no contraindications to thrombolysis\n\nAnalysis of Options:\n\nA. Systemic thrombolysis with weight-based alteplase - This is standard thrombolysis dosing, but in pregnancy, reduced-dose thrombolysis is preferred to minimize fetal/maternal hemorrhage risk.\n\nB. Urgent catheter-directed thrombolysis with reduced-dose alteplase - This allows for:\n- Targeted therapy (lower systemic drug exposure)\n- Reduced-dose alteplase (safer in pregnancy)\n- Mechanical thrombectomy capability if needed\n- Better hemodynamic monitoring during procedure\n- Reduced fetal exposure compared to systemic thrombolysis\n\nC. Surgical embolectomy - Reserved for when thrombolysis is contraindicated or has failed; not first-line even in pregnancy with massive PE.\n\nD. Heparin alone and defer - Unacceptable; patient is hemodynamically unstable with RV dysfunction. Anticoagulation alone is insufficient for massive PE. Deferring to postpartum risks maternal death.\n\nE. Tenecteplase bolus - Single-bolus thrombolysis is convenient but uses standard dosing; catheter-directed approach is preferred in pregnancy.\n\nRationale for B:\nIn pregnant patients with massive PE requiring thrombolysis, catheter-directed thrombolysis with reduced-dose alteplase is preferred because it:\n1. Minimizes systemic drug exposure to fetus\n2. Allows mechanical thrombectomy if needed\n3. Provides hemodynamic monitoring\n4. Is safer than full-dose systemic thrombolysis in pregnancy\n5. Addresses the life-threatening hemodynamic instability\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-007", "question": "A 28-year-old woman presents with recurrent episodes of suddenly \"losing time\" for several hours, during which she is observed by coworkers to function at her high-stress job but later has no recollection of events. She reports chronic depersonalization, multiple unexplained somatic complaints, and a history of severe childhood emotional neglect but denies frank physical or sexual abuse. Neurologic examination and prolonged video EEG are normal, and there is no substance use. She is distressed by the amnesia but also describes the episodes as an \"escape\" from overwhelming emotions. Which of the following psychotherapeutic approaches is most appropriate as a primary treatment strategy at this stage?", "options": ["High-frequency supportive psychodynamic psychotherapy focused on strengthening defenses and minimizing exploration of trauma content", "Trauma-focused exposure therapy directly targeting the amnestic episodes with in vivo and imaginal exposure", "Phase-oriented trauma therapy emphasizing stabilization, skills for affect regulation, and gradual integration of dissociative states", "Manualized cognitive processing therapy focusing on cognitive restructuring of maladaptive trauma-related beliefs without addressing dissociation", "Hypnotic age-regression therapy aimed at recovering repressed memories of early childhood to reduce dissociative barriers"], "answer": "C", "answer_index": 2, "explanation": "This presentation is most consistent with a dissociative disorder; evidence and expert guidelines favor phase-oriented trauma therapy beginning with stabilization and affect regulation before intensive trauma processing. Immediate trauma-focused exposure or memory-recovery approaches (B, E) can worsen dissociation; purely supportive (A) or cognitive-processing (D) strategies without addressing dissociation are insufficient as primary treatment.", "generator_model": "gpt-5.1-2025-11-13", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed129", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed129-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed129.jsonl", "pred": "C", "model_outputs": "This question describes a patient with Dissociative Identity Disorder (DID) or Other Specified Dissociative Disorder (OSDD), characterized by:\n- Recurrent amnestic episodes with functioning during lost time\n- Chronic depersonalization\n- Somatic complaints\n- History of severe childhood emotional neglect\n- Normal neurologic workup\n- Distress but also secondary gain (\"escape\")\n\nLet me evaluate each option:\n\nA. High-frequency supportive psychodynamic psychotherapy with defense strengthening:\n- While supportive therapy has a role, this approach is too passive and doesn't address the core dissociative pathology adequately.\n\nB. Trauma-focused exposure therapy with direct targeting of amnestic episodes:\n- This is contraindicated as a PRIMARY approach in dissociative disorders. Direct exposure without stabilization can destabilize patients and worsen dissociation.\n\nC. Phase-oriented trauma therapy (stabilization → processing → integration):\n- This is the gold standard for treating complex trauma and dissociative disorders. The three-phase model (Stabilization/Safety → Processing → Integration) is specifically recommended by trauma experts (van der Kolk, Herman, Courtois). This patient needs stabilization and affect regulation skills BEFORE any trauma processing.\n\nD. Manualized cognitive processing therapy without addressing dissociation:\n- CPT is effective for PTSD but is not appropriate as primary treatment for dissociative disorders, as it doesn't address the core dissociative mechanism.\n\nE. Hypnotic age-regression for memory recovery:\n- This is contraindicated. It can create false memories, destabilize the patient, and worsen dissociation. Memory recovery is not the treatment goal.\n\nThe correct approach for dissociative disorders is phase-oriented treatment starting with stabilization and affect regulation before any trauma processing.\n\nThe answer is C"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-008", "question": "A 63-year-old man with long-standing hypertension and ischemic cardiomyopathy (EF 30%) presents with acute right hemiplegia and aphasia 45 minutes after symptom onset. NIHSS is 18. Noncontrast CT head shows no hemorrhage. CT angiography shows left M1 occlusion with favorable collaterals; CT perfusion suggests a large salvageable penumbra. ECG shows sinus rhythm with frequent PVCs. High-sensitivity troponin is mildly elevated and flat on serial testing. You plan IV thrombolysis and urgent mechanical thrombectomy. Which of the following additional acute management steps is most appropriate?", "options": ["Initiate IV unfractionated heparin infusion before mechanical thrombectomy due to high cardioembolic risk", "Administer IV labetalol to reduce blood pressure to <140/90 mm Hg prior to thrombolysis", "Start high-dose statin and delay any antiplatelet therapy until 24 hours after thrombolysis", "Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis", "Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "The correct step is to start high-intensity statin immediately and delay antiplatelets until 24 hours after thrombolysis and repeat imaging, per acute ischemic stroke guidelines. Heparin before thrombectomy (A) increases hemorrhagic risk with no proven benefit. Lowering BP below 140/90 (B) before tPA is too aggressive and can worsen cerebral perfusion; only treat if >185/110 to that threshold. Dual antiplatelets immediately after tPA (D) markedly increases hemorrhage risk. Intra-aortic balloon pump (E) has no role in this setting and carries procedural risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_question_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251129T045001943Z_gpt-5.1-2025-11-13_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T045001943Z_gpt-5.1-2025-11-13_seed124.jsonl", "pred": "C", "model_outputs": "Let me work through this acute ischemic stroke case systematically.\n\nClinical Context:\n- Acute ischemic stroke (M1 occlusion) within thrombolytic window (45 min)\n- NIHSS 18 (moderate-severe)\n- Favorable imaging for intervention\n- Patient has cardiomyopathy (EF 30%) with mildly elevated troponin\n- Plan: IV thrombolysis + mechanical thrombectomy\n\nAnalyzing Each Option:\n\nA. IV unfractionated heparin before thrombectomy due to cardioembolic risk\n- Heparin is NOT routinely given before or during mechanical thrombectomy in standard protocols\n- Anticoagulation during thrombectomy is not standard practice and increases bleeding risk\n- This is not appropriate acute management\n\nB. IV labetalol to reduce BP to <140/90 mm Hg prior to thrombolysis\n- Blood pressure management in acute stroke is nuanced\n- For thrombolysis candidates, BP targets are typically <185/110 mm Hg (more permissive)\n- Aggressive BP lowering to <140/90 mm Hg is NOT recommended before thrombolysis\n- This could compromise cerebral perfusion in the setting of large vessel occlusion\n- This is inappropriate\n\nC. Start high-dose statin and delay antiplatelet therapy until 24 hours after thrombolysis\n- Statins should be started but this is not the most acute/critical decision\n- Antiplatelet therapy timing: Aspirin is typically given AFTER thrombolysis (within 24 hours)\n- Delaying antiplatelet therapy is reasonable but not the \"most appropriate\" acute step\n- This is reasonable but not the best answer\n\nD. Begin dual antiplatelet therapy with aspirin and clopidogrel immediately after thrombolysis\n- Aspirin after thrombolysis is standard\n- However, dual antiplatelet therapy (aspirin + clopidogrel) immediately after thrombolysis is NOT standard\n- Clopidogrel loading is typically reserved for stent placement during thrombectomy or later management\n- This is not standard acute stroke protocol\n\nE. Place an intra-aortic balloon pump preemptively to support cerebral perfusion during thrombectomy\n- IABP is not indicated for acute stroke management\n- It's used for cardiogenic shock, not cerebral perfusion support\n- This is inappropriate and not standard care\n\nReconsidering the options:\nThe question asks for \"most appropriate additional acute management steps.\" Given the patient's cardiomyopathy and the clinical scenario, B regarding blood pressure management is actually problematic because aggressive lowering is contraindicated.\n\nActually, reviewing C more carefully: Starting statins and appropriate antiplatelet timing (aspirin after thrombolysis, not dual therapy immediately) represents sound acute management principles.\n\nHowever, the most clinically appropriate step in this specific scenario with a large vessel occlusion and favorable penumbra would be ensuring proper BP management - but NOT aggressive lowering. The standard approach is to keep BP <185/110 before thrombolysis.\n\nGiven the options, C represents the most appropriate additional management (statin initiation and proper antiplatelet sequencing).\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-009", "question": "A 13-year-old girl presents with 1 year of fatigue and exercise intolerance. She has short stature, sensorineural hearing loss, mild ptosis, and a maternal family history of early-onset diabetes and deafness. BMI is 18 kg/m². Random glucose is 230 mg/dL, HbA1c 8.1%. C-peptide is low-normal, and GAD65, IA-2, and ZnT8 antibodies are negative. Lactate is mildly elevated at baseline and rises disproportionately after minimal exercise. Which of the following is the most appropriate initial pharmacologic management of her hyperglycemia?", "options": ["High-dose metformin monotherapy titrated to maximum tolerated dose", "Immediate initiation of a basal-bolus insulin regimen", "Sulfonylurea monotherapy due to likely KATP channel mutation", "GLP-1 receptor agonist therapy to improve insulin secretion", "SGLT2 inhibitor added to lifestyle therapy to decrease renal glucose reabsorption"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with mitochondrial diabetes (e.g., MIDD) in the context of multisystem mitochondrial disease, for which insulin is preferred due to β-cell failure and risk of lactic acidosis with metformin. Sulfonylureas are indicated in many KATP-channel MODY forms, not mitochondrial disease. GLP-1 agonists and SGLT2 inhibitors are not first-line in pediatric mitochondrial diabetes and have limited safety data in this context.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "B", "model_outputs": "Let me analyze this case systematically.\n\nKey Clinical Features:\n1. 13-year-old girl with diabetes\n2. Short stature, sensorineural hearing loss, mild ptosis\n3. Maternal family history of early-onset diabetes and deafness\n4. Normal BMI (not obese)\n5. Elevated glucose (230 mg/dL) and HbA1c (8.1%)\n6. Low-normal C-peptide (some residual beta cell function)\n7. Negative autoimmune markers (GAD65, IA-2, ZnT8) - rules out Type 1 diabetes\n8. Mildly elevated lactate at baseline that rises disproportionately with minimal exercise - this is the critical clue\n\nDiagnosis:\nThe combination of:\n- Maternal inheritance pattern\n- Sensorineural hearing loss\n- Short stature\n- Ptosis\n- Diabetes\n- Lactic acidosis with exercise\n\nThis is classic for MELAS syndrome or mitochondrial diabetes (maternally inherited diabetes and deafness - MIDD).\n\nThe disproportionate lactate rise with minimal exercise is pathognomonic for mitochondrial dysfunction.\n\nWhy each option is wrong:\n- A (Metformin): Contraindicated in mitochondrial disease due to risk of lactic acidosis\n- C (Sulfonylurea): Not indicated; this isn't a KATP channel mutation\n- D (GLP-1 agonist): Not first-line for mitochondrial diabetes\n- E (SGLT2 inhibitor): Not appropriate as initial therapy\n\nWhy B is correct:\nIn mitochondrial diabetes with evidence of lactic acidosis, insulin is the safest option because:\n1. It avoids metformin (lactic acidosis risk)\n2. It avoids agents that stress mitochondrial function\n3. It directly addresses hyperglycemia without metabolic complications\n4. The low-normal C-peptide suggests some beta cell dysfunction requiring insulin support\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gpt-5.1-2025-11-13_p05", "question_id": "ABMS20260101_gpt-5.1-2025-11-13_p05-010", "question": "A 9-year-old boy presents with recurrent episodes of facial flushing, headache, tachycardia, and severe hypertension. Episodes last 20-30 minutes and resolve spontaneously. Between episodes, his blood pressure is mildly elevated. Exam shows café-au-lait macules and multiple cutaneous neurofibromas. Plasma free metanephrines are markedly elevated. MRI abdomen shows a 2.5-cm left adrenal mass and a 1.2-cm right adrenal mass. Genetic testing is pending. Which of the following is the most appropriate next step in management?", "options": ["Unilateral laparoscopic left adrenalectomy to minimize risk of adrenal insufficiency", "Bilateral laparoscopic adrenalectomy with lifelong glucocorticoid and mineralocorticoid replacement", "Begin nonselective beta-blocker therapy, then alpha-blockade after HR control", "Initiate alpha-adrenergic blockade followed by beta-blockade and plan for cortical-sparing adrenal surgery", "Observe with annual imaging because most pediatric pheochromocytomas regress spontaneously"], "answer": "D", "answer_index": 3, "explanation": "This child with NF1 and bilateral adrenal lesions likely has hereditary pheochromocytomas; preoperative management requires alpha-blockade first, then beta-blockade, followed by surgery. In hereditary/bilateral disease, cortical-sparing adrenalectomy is preferred to reduce long-term adrenal insufficiency risk. Beta-blockade before alpha-blockade can precipitate a hypertensive crisis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gpt-5.1-2025-11-13/20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T225810101Z_gpt-5.1-2025-11-13_seed128.jsonl", "pred": "D", "model_outputs": "Let me work through this systematically.\n\nKey Clinical Features:\n- 9-year-old boy with classic pheochromocytoma symptoms (flushing, headache, tachycardia, hypertension)\n- Café-au-lait macules and neurofibromas = Neurofibromatosis type 1 (NF1)\n- Markedly elevated plasma free metanephrines (confirms pheochromocytoma)\n- Bilateral adrenal masses (2.5 cm left, 1.2 cm right)\n- Genetic testing pending (likely to confirm NF1)\n\nCritical Considerations:\n\n1. NF1 and Pheochromocytoma: Patients with NF1 have a 1-5% risk of pheochromocytoma, and these are often bilateral (25-30% of cases in NF1 vs. 10% in sporadic cases).\n\n2. Bilateral Disease: With bilateral masses and elevated metanephrines, this is bilateral pheochromocytoma. Unilateral surgery would leave functioning tumor tissue.\n\n3. Medical Management First: Before any surgery, patients with pheochromocytoma require:\n   - Alpha-blockade first (to prevent hypertensive crisis during surgery)\n   - Then beta-blockade (after alpha-blockade to avoid unopposed alpha effects)\n\n4. Surgical Approach: For bilateral pheochromocytomas, bilateral adrenalectomy is typically necessary. However, cortical-sparing surgery (removing only the medulla) is increasingly preferred in select cases to preserve adrenal cortical function and avoid lifelong hormone replacement.\n\n5. Option Analysis:\n   - A: Unilateral surgery inappropriate for bilateral disease\n   - B: Bilateral adrenalectomy correct, but doesn't address preoperative medical management\n   - C: Beta-blocker first is wrong (should be alpha first)\n   - D: Alpha-blockade first ✓, then beta-blockade ✓, cortical-sparing surgery ✓ (preserves function)\n   - E: Observation inappropriate for symptomatic bilateral disease with elevated metanephrines\n\nAnswer D is most appropriate because it addresses:\n1. Correct medical preoperative preparation (alpha then beta)\n2. Bilateral disease management\n3. Cortical-sparing approach to minimize morbidity\n\nThe answer is (D)"}]